AGEX THERAPEUTICS INC (AGE) Stock Balance Sheet
NYSEARCA:AGE - NYSE Arca - US00848H2076 - Common Stock - Currency: USD
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 400.00K | 650.00K | 580.00K | 530.00K | 2.35M | |||
| Receivables | 70.00K | 0.00 | 30.00K | 330.00K | 360.00K | |||
| Other Current Assets | 670.00K | 1.80M | 1.63M | 1.43M | 1.34M | |||
| Total Current Assets | 1.14M | 2.45M | 2.23M | 2.28M | 4.05M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | N/A | 0.00 | 1.13M | |||
| Intangibles | 640.00K | 740.00K | 870.00K | 1.59M | 2.15M | |||
| Other Non-Current Assets | 50.00K | 50.00K | 50.00K | 50.00K | 110.00K | |||
| Total Non-Current Assets | 11.07M | 790.00K | 920.00K | 1.65M | 3.39M | |||
| TOTAL ASSETS | 12.21M | 3.24M | 3.15M | 3.93M | 7.44M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 440.00K | 0.00 | |||
| Current Portion Of LT Debt. | 1.53M | 7.65M | 7.14M | 1.96M | N/A | |||
| Accrued Expenses | 500.00K | 470.00K | 580.00K | 900.00K | 1.59M | |||
| Accounts Payable | 1.17M | 570.00K | 190.00K | 760.00K | 420.00K | |||
| Other Current Liabilities | 10.00K | 1.40M | 1.06M | 1.31M | 1.29M | |||
| Total Current Liabilities | 3.20M | 10.08M | 8.97M | 5.36M | 3.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 690.00K | 10.48M | 6.06M | 3.90M | 1.53M | |||
| Other Non-Current Liabilities | N/A | N/A | 0.00 | 60.00K | N/A | |||
| Total Non-Current Liabilities | 590.00K | 10.37M | 6.02M | 3.68M | 1.92M | |||
| TOTAL LIABILITIES | 3.79M | 20.45M | 14.99M | 9.04M | 5.22M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -127.56M | -116.21M | -105.75M | -97.07M | -86.21M | |||
| Additional Paid In Capital | 100.02M | 98.99M | 93.91M | 91.81M | 88.35M | |||
| Minority Interest | -110.00K | -100.00K | -40.00K | -280.00K | 400.00K | |||
| Common Shares | 35.96M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | 140.00K | 70.00K | |||
| Shares Outstanding | 37.95M | 37.95M | 37.94M | 37.69M | 37.65M | |||
| Tangible Book Value per Share | -0.74 | -0.47 | -0.33 | -0.18 | 0.00 | |||
| Total Shareholders' Equity | 8.42M | -17.21M | -11.83M | -5.12M | 2.22M | |||
| TOTAL LIABILITIES AND EQUITY | 12.21M | 3.24M | 3.15M | 3.93M | 7.44M | |||
| Statistics | ||||||||
| Debt/Equity | 0.08 | -0.61 | -0.51 | -0.85 | 0.69 | |||
| Current Ratio | 0.36 | 0.24 | 0.25 | 0.43 | 1.23 | |||
| Return On Assets (ROA) | -115.07% | -322.84% | -275.56% | -276.59% | -163.31% | |||
| Return On Equity (ROE) | -166.86% | N/A | N/A | N/A | -547.30% | |||
All data in USD , ROIC based on taxRate of 0.21